Form EFFECT Entrada Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 3, 2025 4:01 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Information regarding executed transactions within the framework of a share buyback programme (outside the liquidity agreement) from 24 August to 28 August 2026
- Everbridge and Arcadis Partner to Help Organizations Assess and Manage Climate Risk
- Virtual Card Maker Highlights Upfront Spending Controls for Project Teams
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
